NZ757218A - Complex containing oligonucleotide having immunopotentiating activity and use thereof - Google Patents
Complex containing oligonucleotide having immunopotentiating activity and use thereofInfo
- Publication number
- NZ757218A NZ757218A NZ757218A NZ75721814A NZ757218A NZ 757218 A NZ757218 A NZ 757218A NZ 757218 A NZ757218 A NZ 757218A NZ 75721814 A NZ75721814 A NZ 75721814A NZ 757218 A NZ757218 A NZ 757218A
- Authority
- NZ
- New Zealand
- Prior art keywords
- complex containing
- containing oligonucleotide
- immunopotentiating activity
- oligodeoxynucleotide
- provides
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- 230000002434 immunopotentiative effect Effects 0.000 title 1
- 229940046168 CpG oligodeoxynucleotide Drugs 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 229940046166 oligodeoxynucleotide Drugs 0.000 abstract 2
- WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 abstract 1
- 229920002498 Beta-glucan Polymers 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229920002305 Schizophyllan Polymers 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides an oligodeoxynucleotide containing humanized K-type CpG oligodeoxynucleotide, polydeoxyadenylic acid and schizophyllan, wherein polydeoxyadenylic acid is located on the 3’ side of the humanized K-type CpG oligodeoxynucleotide. The present invention also provides a complex containing this oligodeoxynucleotide and β-1,3-glucan and use thereof in the manufacture of a medicament for treatment or prophylaxis of cancer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013196206 | 2013-09-20 | ||
| NZ718900A NZ718900A (en) | 2013-09-20 | 2014-09-19 | Complex containing oligonucleotide having immunopotentiating activity and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ757218A true NZ757218A (en) | 2022-02-25 |
Family
ID=80679538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ757218A NZ757218A (en) | 2013-09-20 | 2014-09-19 | Complex containing oligonucleotide having immunopotentiating activity and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ757218A (en) |
-
2014
- 2014-09-19 NZ NZ757218A patent/NZ757218A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020012133A (en) | Complex containing oligonucleotide having immunopotentiating activity and use thereof. | |
| JOP20200192A1 (en) | Anti-tigit antibodies | |
| ZA201708692B (en) | Antibacterial compounds | |
| PH12016500868A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
| MX2017002856A (en) | Cross reactive siglec antibodies. | |
| MX2020009780A (en) | Autotaxin inhibitor compounds. | |
| NZ631701A (en) | Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases | |
| MX2019013808A (en) | Compounds for treatment of cancer. | |
| PH12016500863A1 (en) | Tetracyclic autotaxin inhibitors | |
| PH12016501095A1 (en) | Gabapentinoids and sigma receptor ligands combinations | |
| MX2017015311A (en) | Combination of an anti-il-10 antibody and a cpg-c type oligonucleotide for treating cancer. | |
| MX2014010940A (en) | The use of antithrombin in the treatment of pre-eclampsia. | |
| MX2017009313A (en) | Intravenous baclofen formulations and treatment methods. | |
| NZ757218A (en) | Complex containing oligonucleotide having immunopotentiating activity and use thereof | |
| MX2020006430A (en) | Oligonucleotides comprising a phosphorodithioate internucleoside linkage. | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| LV15384A (en) | 1-acetyl-5-nitro-4-phenyl-3-pyrrolin-2-one for use in the treatment of cancer | |
| TN2014000370A1 (en) | Pharmaceutical diagnostic | |
| IN2013MU03855A (en) | ||
| RU2013113770A (en) | ANTI-TUMOR ACTIVITY PRODUCT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 SEP 2023 BY CPA GLOBAL Effective date: 20220804 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 SEP 2024 BY CPA GLOBAL Effective date: 20230803 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 SEP 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20240809 |